Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer.
about
Targeted drugs in small-cell lung cancerSmall cell lung cancer (SCLC): no treatment advances in recent yearsNovel therapies in small cell lung cancerGenomic profiling of small-cell lung cancer: the era of targeted therapiesTargeting angiogenesis in small cell lung cancerAngiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials.Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer.Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.Efficacy and safety of angiogenesis inhibitors in small-cell lung cancerIncidence and risk of severe infections associated with aflibercept in cancer patients: a systematic review and meta-analysisDisease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database.Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?Natural history and outcome of neuroendocrine carcinoma of the cervix.Osteonecrosis of the jaw associated with ziv-afliberceptAdvances in antiangiogenic treatment of small-cell lung cancer.Relapsed small cell lung cancer: treatment options and latest developments.An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients.A Phase 2 Study of 5-Fluorouracil (5-FU), Ziv-Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients with Stage II/III Rectal Cancer.Therapies in the pipeline for small-cell lung cancer.Progress and challenges in the treatment of small cell lung cancer.Second-line treatments of small-cell lung cancers.[Advances in the Treatment of Relapsed Small Cell Lung Cancer].Advanced small cell lung cancer (SCLC): new challenges and new expectations.Tumor angiogenesis and anti-angiogenic gene therapy for cancer.
P2860
Q26767017-AA55D8BF-E937-47FD-9A95-A73838D25258Q26767020-5C38C57F-8F1B-4287-92ED-8DD6D5692A3DQ26775390-2E1BFF89-313A-42F7-BD53-B4515E5E887CQ26826915-D14A9687-494F-4808-B965-50403E87F1FFQ28068385-C80EF5C8-72E6-4084-AA9F-B5EEFE04A8D7Q30235046-D1DC458C-C8C0-4013-82C1-22B3574C8EFCQ33443519-EBD9482D-E081-4CF8-A5D8-76B41162C3D1Q34452827-4FD1C8CD-4C81-4623-9AC9-13FAC1BA30DFQ36207730-03533211-CB62-433E-9DB9-1E37052F1660Q36410268-3173AAC0-5D11-49CA-8054-2D3249C5F554Q36680046-2B2B8F94-59DB-421F-A748-42F8A81241E3Q36811784-582A3880-C1DC-413F-BCDD-3C27C83AC5D2Q36834895-1CFD8155-29D0-4A5D-BAC9-17C42C91B4C9Q37525339-2DCBC4B9-B513-4780-9867-48AA37F840A0Q37588040-D520A7A8-2BF3-4680-B88B-4DEED1649794Q37598178-381CF124-E8FB-41CB-87E2-2E0FF3616CA9Q38525073-A1D8DB68-A693-42B3-8BE9-489CD3340400Q38612645-E849A88D-420C-4FC8-BAB4-D3666593976BQ38632534-A92C4551-C497-4986-A3ED-A84DEBBEBB2EQ38871386-5BFC36CE-2763-4B2B-B730-88E31AF722A8Q39272825-0E7E54E3-E2C1-4DDE-8518-DD9A3A3DF87EQ47789861-A87AFCB3-1970-4A05-9A36-1A236A8FD002Q53747313-73E0E5FB-306B-4C78-95EA-DA230A17DE62Q54977232-E10A97CA-6854-4E96-A57E-CF44038C9D11Q55385227-19C70A02-383A-4152-8E42-11DF2468D2F7
P2860
Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@ast
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@en
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@nl
type
label
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@ast
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@en
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@nl
prefLabel
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@ast
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@en
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@nl
P2093
P2860
P356
P1476
Southwest Oncology Group S0802 ...... reated small-cell lung cancer.
@en
P2093
Hanna M Saba
James Moon
Jeffrey W Allen
Mary Redman
Mohamed K Mohamed
Mohammad Jahanzeb
Philip C Mack
Shirish M Gadgeel
P2860
P304
P356
10.1200/JCO.2013.51.4109
P407
P577
2014-07-07T00:00:00Z